Cargando…

Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience

Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Alexandre, Joe, Melanie D., Hirsch, Jan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544650/
https://www.ncbi.nlm.nih.gov/pubmed/34698259
http://dx.doi.org/10.3390/pharmacy9040164
_version_ 1784589862200934400
author Chan, Alexandre
Joe, Melanie D.
Hirsch, Jan D.
author_facet Chan, Alexandre
Joe, Melanie D.
Hirsch, Jan D.
author_sort Chan, Alexandre
collection PubMed
description Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 vaccines. UCI SPPS and our affiliated UCI Medical Center (UCIMC) Pharmacy Department partnered to spearhead the pharmacy element of a large-scale COVID-19 vaccination clinic on campus for both employees and the community. Three key initiatives were established in order to overcome the obstacles we faced in the large-scale roll out of COVID-19 vaccines: (1) forging new collaborations within the pharmacy team, (2) leveraging interprofessional education and practice, and (3) raising awareness of the pharmacists’ role. Our response to the COVID-19 vaccines at UCI was a tangible, visible model that demonstrated that, while we continue to embrace our role in team-based, patient-centered care, it is also important for us to step up and lead the profession. Additionally, this vaccine rollout experience is a teachable moment for our communities and our health professional partners as we continue to march forward as one voice to serve the American public.
format Online
Article
Text
id pubmed-8544650
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85446502021-10-26 Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience Chan, Alexandre Joe, Melanie D. Hirsch, Jan D. Pharmacy (Basel) Commentary Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 vaccines. UCI SPPS and our affiliated UCI Medical Center (UCIMC) Pharmacy Department partnered to spearhead the pharmacy element of a large-scale COVID-19 vaccination clinic on campus for both employees and the community. Three key initiatives were established in order to overcome the obstacles we faced in the large-scale roll out of COVID-19 vaccines: (1) forging new collaborations within the pharmacy team, (2) leveraging interprofessional education and practice, and (3) raising awareness of the pharmacists’ role. Our response to the COVID-19 vaccines at UCI was a tangible, visible model that demonstrated that, while we continue to embrace our role in team-based, patient-centered care, it is also important for us to step up and lead the profession. Additionally, this vaccine rollout experience is a teachable moment for our communities and our health professional partners as we continue to march forward as one voice to serve the American public. MDPI 2021-10-09 /pmc/articles/PMC8544650/ /pubmed/34698259 http://dx.doi.org/10.3390/pharmacy9040164 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Chan, Alexandre
Joe, Melanie D.
Hirsch, Jan D.
Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
title Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
title_full Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
title_fullStr Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
title_full_unstemmed Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
title_short Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
title_sort supporting covid-19 vaccine rollout before charter class arrives: the university of california, irvine experience
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544650/
https://www.ncbi.nlm.nih.gov/pubmed/34698259
http://dx.doi.org/10.3390/pharmacy9040164
work_keys_str_mv AT chanalexandre supportingcovid19vaccinerolloutbeforecharterclassarrivestheuniversityofcaliforniairvineexperience
AT joemelanied supportingcovid19vaccinerolloutbeforecharterclassarrivestheuniversityofcaliforniairvineexperience
AT hirschjand supportingcovid19vaccinerolloutbeforecharterclassarrivestheuniversityofcaliforniairvineexperience